Skip to content
Dx

HCPCS Level II · Miscellaneous services (temporary codes)

Q2042Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About Q2042

Q2042 is an HCPCS Level II code in the Q series (miscellaneous services (temporary codes)), describing tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose.

It was added to HCPCS effective 01/01/2019.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Tisagenlecleucel car-pos t
Date added
01/01/2019
Action effective
01/01/2019
BETOS
O1E

Related Q20xx codes

Common questions about Q2042

Is HCPCS Q2042 still valid?

Yes. Q2042 is active in the CMS October 2026 HCPCS file.

Does Medicare cover Q2042?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.